Sunday, February 02, 2014 7:23:13 PM
The SP got into the 5.4 to 5.5 range where it was relatively safe from being pulled back to the critical $5 level that would trigger margin sales (some fully automatic and in real time at IBs)and a futher plunge and then held down until margin calls were over. As those waiting for that zone to add into margin accounts started piling on, the SP began to take off. Encouraged by the momentum and increasing volume that the SP was going to get well away from the danger zone more piled on. And they almost certainly would have been right expect for the unexpected offering.
Whatever the reason for the rise, it added a good 25 to 30 cents to the offering price.
If you calculate dilution from the offering into the closing price of 5.25 you get about the drop that occurred. So IMHO it's reasonable to say that the market has done their dip in response to the offering. The SP dipped very similarly with the last offering and fully recovered in less than two weeks and then continued upwards. IMHO because investors (or those who bought in) realized that the offering (as now) was for a very good purpose which had highly positive implications (then it was to move to a higher exchange and expand activity on drug development as a response to getting Orphan Drug designation for Dengue from both the FDA and the EMA. Now it's for more rapid development for selected targets as an appropriate response to the remarkably good toxicity data in the dose ranging study. I would expect therefor for the SP to react much the same except that it may not go up quite as far due to the market wide problems. I would be very surprised if it doesn't get to the mid fives within a couple of weeks. JMHO
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
FEATURED North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM